Alzheon

Details

city

Framingham

continent

North America

country

United States

has patents

true

industry

health

patent count estimate

5

total funding usd

94000000

unicorn

true

unicorn since

2020-09-30

valuation usd

1000000000

year founded

2013

competes with → company3

• Biogen (Aduhelm / aducanumab)
• Eisai/Biogen (Leqembi / lecanemab)
• Eli Lilly (Kisunla / donanemab)

company → invested in2

• Ally Bridge Group
• ARCH Venture Partners

based in → country1

• United States

member of → category1

• Healthtech

owns → patent1

• Alzheon Patents